Paragonix Technologies Announces Global Registry for Pediatric Donor Heart Preservation; Enrolls First Patient
Paragonix Technologies, Inc. today announces that the University of Florida Health (UF Health) is the first to enroll a pediatric heart transplant recipient into the Companys post-market registry, the Global Utilization And Registry Database for Improved preservAtion of donor HEARTs (GUARDIAN-HEART) Pediatric Registry.
- Paragonix Technologies, Inc. today announces that the University of Florida Health (UF Health) is the first to enroll a pediatric heart transplant recipient into the Companys post-market registry, the Global Utilization And Registry Database for Improved preservAtion of donor HEARTs (GUARDIAN-HEART) Pediatric Registry.
- Paragonix SherpaPak CTS is the only commercially available FDA-cleared and CE-marked medical device for heart transportation and the only device to fit small pediatric donor hearts.
- A clinical registry dedicated to improving the preservation of the donor heart has the potential to save lives.
- The global clinical study is registered at clinicaltrials.gov and is open to all pediatric heart transplant centers that are looking to analyze patient outcomes based on donor heart preservation methods.